表紙
市場調査レポート

遠隔医療(テレメディスン):主流の治療法への移行過程

Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment

発行 CBR Pharma Insights 商品コード 276865
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
遠隔医療(テレメディスン):主流の治療法への移行過程 Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment
出版日: 2013年07月22日 ページ情報: 英文
概要

近年、テレラジオロジー(遠隔放射線診断)・テレパソロジー(遠隔病理診断)・テレダーマトロジー(遠隔皮膚科治療)などの分野でテレメディスン(遠隔医療)に対する関心が高まっています。遠隔医療は最初は主に軍事・航空宇宙部門で使われ、現在では農村部むけサービスとして利用されていますが、今後はさらに幅広い分野で活用されるものと思われます。

当レポートでは、世界各国での遠隔医療の開発・活用状況について分析し、これまでの開発・発展の流れや、今後解決すべき問題、具体的な活用事例、今後の見通しなどを調査して、その結果を概略以下の構成でお届けします。

エグゼクティブ・サマリー

第1章 遠隔医療の発展

  • 遠隔医療の発展
  • 遠隔医療の種類
  • 遠隔医療はどこで利用されているのか
  • 遠隔医療の拡張

第2章 遠隔医療の主な課題

  • ライセンス交付
  • 医療費償還
  • 法規
  • 規制
  • 課税

第3章 ケーススタディ

  • 皮膚科
  • 神経科
  • 糖尿病
  • 英国の事例:心臓病・糖尿病・COPD(慢性閉塞性肺疾患)
  • 高齢患者
  • 集中治療
  • テレファーマシー(遠隔調剤)

第4章 遠隔医療の将来展望

  • 医療改革の影響
  • 新技術
  • CBRの見解

付録

目次
Product Code: CBRSV045

Telemedicine is a creation of the 20th century. First used primarily for military and space applications, it has been becoming more widespread in use in recent years. There are three main types of telemedicine applications: store-and-forward, remote monitoring and interactive services.

Interest in telemedicine is growing globally, particularly in the fields of teleradiology, telepathology and teledermatology. Globally, cost is seen as the major barrier to telemedicine programs. In the US, telemedicine has been promoted as a way to serve rural populations, but in the next few years it is expected to spread to a much wider patient base.

A number of key challenges still need to be addressed for the use of telemedicine to become more widespread in the US. Licensing and reimbursement remain major hurdles to physician participation in telemedicine.

These challenges are being addressed at the state level, with an increasing number of state legislatures taking up the issues. There is also federal legislation being looked at by Congress. Issues of FDA Regulation and possible issues of taxation also need to be clarified to help promote wider use of telemedicine.

The report, “Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment” was written to support both the biopharmaceutical and health care industries in understanding the use of telemedicine and preparing for the expected growth it will see in the coming years. This report provides data, analysis, and CBR's insights on this key growth market and where the challenges to it may exist.

Key Reasons to Purchase

  • This comprehensive study can be used to compare the effectiveness of the different telemedicine applications available CBR's insights and case study analysis
  • Companies can assess the impact of health care reform on telemedicine uptake now and in the future
  • Gain insights on the key challenges that exist to further expansion of telemedicine programs and how they can be overcome
  • Better evaluate the potential for telepharmacy programs, a key area of opportunity for the pharmaceutical industry
  • Utilize the insights from this study to analyze the barriers facing wider adoption of telemedicine

Table of Contents

Executive Summary

Chapter 1: Development of Telemedicine

  • Development of Telemedicine
  • Types of Telemedicine
  • Where Telemedicine is being Used
  • Expansion of Telemedicine

Chapter 2: Key Challenges to Telemedicine

  • Licensing
  • Reimbursement
  • Legislation
  • Regulation
  • Taxation

Chapter 3: Case Studies

  • Dermatology
  • Neurology
  • Diabetes
  • A UK Study - Heart Disease, Diabetes, and COPD
  • Elderly Patients
  • Intensive Care
  • Telepharmacy

Chapter 4: The Outlook for Telemedicine

  • The Impact of Health Care Reform
  • New Technologies
  • The CBR View

Appendix

Total Report Size - 48 slides; fully sourced.

Back to Top